Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Javier Rúiz-Martínez"'
Autor:
Tomás Cordero-Lanzac, Izar Capel Berdiell, Alessia Airi, Sang-Ho Chung, Jenna L. Mancuso, Evgeniy A. Redekop, Claudia Fabris, Leidy Figueroa-Quintero, Juan C. Navarro de Miguel, Javier Narciso, Enrique V. Ramos-Fernandez, Stian Svelle, Veronique Van Speybroeck, Javier Ruiz-Martínez, Silvia Bordiga, Unni Olsbye
Publikováno v:
JACS Au, Vol 4, Iss 2, Pp 744-759 (2024)
Externí odkaz:
https://doaj.org/article/cee82a00e1004c9ab4886952b3cc0855
Autor:
Ane Murueta-Goyena, David Romero-Bascones, Sara Teijeira-Portas, J. Aritz Urcola, Javier Ruiz-Martínez, Rocío Del Pino, Marian Acera, Axel Petzold, Siegfried Karl Wagner, Pearse Andrew Keane, Unai Ayala, Maitane Barrenechea, Beatriz Tijero, Juan Carlos Gómez Esteban, Iñigo Gabilondo
Publikováno v:
npj Parkinson's Disease, Vol 10, Iss 1, Pp 1-10 (2024)
Abstract Retinal thickness may serve as a biomarker in Parkinson’s disease (PD). In this prospective longitudinal study, we aimed to determine if PD patients present accelerated thinning rate in the parafoveal ganglion cell-inner plexiform layer (p
Externí odkaz:
https://doaj.org/article/d5f9a3a2534a44e5b071c103f6740ef3
Autor:
Yahaira Naaldijk, Belén Fernández, Rachel Fasiczka, Elena Fdez, Coline Leghay, Ioana Croitoru, John B. Kwok, Yanisse Boulesnane, Amelie Vizeneux, Eugenie Mutez, Camille Calvez, Alain Destée, Jean-Marc Taymans, Ana Vinagre Aragon, Alberto Bergareche Yarza, Shalini Padmanabhan, Mario Delgado, Roy N. Alcalay, Zac Chatterton, Nicolas Dzamko, Glenda Halliday, Javier Ruiz-Martínez, Marie-Christine Chartier-Harlin, Sabine Hilfiker
Publikováno v:
npj Parkinson's Disease, Vol 10, Iss 1, Pp 1-13 (2024)
Abstract Parkinson´s disease (PD) is a common neurodegenerative movement disorder and leucine-rich repeat kinase 2 (LRRK2) is a promising therapeutic target for disease intervention. However, the ability to stratify patients who will benefit from su
Externí odkaz:
https://doaj.org/article/c64a6d54ee0f438bada89215f582520b
Autor:
Saul Martínez-Horta, Helena Bejr-Kasem, Andrea Horta-Barba, Berta Pascual-Sedano, Diego Santos-García, Teresa de Deus-Fonticoba, Silvia Jesús, Miquel Aguilar, Lluis Planellas, Juan García-Caldentey, Nuria Caballol, Bárbara Vives-Pastor, Jorge Hernández-Vara, Iria Cabo-Lopez, Lydia López-Manzanares, Isabel González-Aramburu, Maria Asunción Ávila-Rivera, Maria Jose Catalán, Luis Manuel López-Díaz, Victor Puente, Jose Manuel García-Moreno, Carmen Borrué, Berta Solano-Vila, Maria Álvarez-Sauco, Lydia Vela, Sonia Escalante, Esther Cubo, Francisco Carrillo-Padilla, Juan Carlos Martínez-Castrillo, Pilar Sánchez-Alonso, Maria Gema Alonso-Losada, Nuria López-Ariztegui, Itziar Gastón, Marta Blázquez-Estrada, Manual Seijo-Martínez, Javier Rúiz-Martínez, Caridad Valero-Merino, Monica Kurtis, Oriol de Fábregues-Boixar, Jessica González-Ardura, Cristina Prieto-Jurczynska, Pablo Martinez-Martin, Pablo Mir, Jaime Kulisevsky, COPPADIS Study Group
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Identifying modifiable risk factors for cognitive impairment in the early stages of Parkinson’s disease (PD) and estimating their impact on cognitive status may help prevent dementia (PDD) and the design of cognitive trials. Met
Externí odkaz:
https://doaj.org/article/0b9e0017c31e42568071f0f6b4ae9a90
Autor:
Diego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, Maria J. Feal Painceiras, Maria Cristina Íñiguez-Alvarado, Silvia Jesús, Maria Teresa Buongiorno, Lluís Planellas, Marina Cosgaya, Juan García Caldentey, Nuria Caballol, Ines Legarda, Jorge Hernández Vara, Iria Cabo, Lydia López Manzanares, Isabel González Aramburu, Maria A. Ávila Rivera, Víctor Gómez Mayordomo, Víctor Nogueira, Víctor Puente, Julio Dotor García-Soto, Carmen Borrué, Berta Solano Vila, María Álvarez Sauco, Lydia Vela, Sonia Escalante, Esther Cubo, Francisco Carrillo Padilla, Juan C. Martínez Castrillo, Pilar Sánchez Alonso, Maria G. Alonso Losada, Nuria López Ariztegui, Itziar Gastón, Jaime Kulisevsky, Marta Blázquez Estrada, Manuel Seijo, Javier Rúiz Martínez, Caridad Valero, Mónica Kurtis, Oriol de Fábregues, Jessica González Ardura, Ruben Alonso Redondo, Carlos Ordás, Luis M. L. López Díaz, Darrian McAfee, Pablo Martinez-Martin, Pablo Mir, Study Group COPPADIS
Publikováno v:
Scientia
Introduction. Drooling in Parkinson’s disease (PD) is frequent but often goes underrecognized. Our aim was to examine the prevalence of drooling in a PD cohort and compare it with a control group. Specifically, we identified factors associated with
Autor:
Marina Cosgaya, Jose M. Paz González, Esther Cubo, Maria G. Alonso Losada, Nuria López Ariztegui, Isabel González Aramburu, Carmen Borrué, Lydia López Manzanares, Jaime Kulisevsky, Iria Cabo, Julio Dotor García-Soto, Pau Pastor, Carlos Cores Bartolomé, Nuria Caballol, Jessica González Ardura, Lucía García Roca, Berta Solano Vila, Luis M. López Díaz L, Víctor Puente, Pablo Martinez-Martin, Juan García Caldentey, Javier Rúiz Martínez, Lydia Vela, Cristina Martínez Miró, Itziar Gastón, Lucía Naya Ríos, Francisco Carrillo Padilla, Ruben Alonso Redondo, Darrian McAfee, Juan C. Martínez Castrillo, Ines Legarda, Silvia Jesús, Carlos Ordás, Víctor Nogueira, Marta Blázquez Estrada, Oriol de Fábregues, Miquel Aguilar, Hector Canfield, Manuel Seijo, Teresa de Deus Fonticoba, Jorge Hernández Vara, Maria A. Ávila Rivera, Pablo Mir, Pilar Sánchez Alonso, Diego Santos García, Lluis Planellas, Caridad Valero, Monica M. Kurtis, Víctor Gómez Mayordomo, Sonia Escalante, María Álvarez Sauco
Publikováno v:
Journal of Parkinsons Disease
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
[Background] Constipation has been linked to cognitive impairment development in Parkinson’s disease (PD). Objective:Our aim was to analyze cognitive changes observed in PD patients and controls from a Spanish cohort with regards to the presence or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e64a9cb2d616315aceae302a1f891268
http://hdl.handle.net/10261/305139
http://hdl.handle.net/10261/305139
Autor:
Ines Legarda, Diego Santos García, Iria Cabo, Carmen M. Labandeira, Isabel González Aramburu, Juan C. Martínez Castrillo, Esther Cubo, Teresa de Deus Fonticoba, Bárbara Vives, Marta Blázquez Estrada, Lydia Vela, Ester Suárez Castro, Nuria Caballol, Juan García Caldentey, Pablo Mir, Pau Pastor, Maria José Catalán, Maria G. Alonso Losada, Nuria López Ariztegui, Marina Cosgaya, Carmen Borrué, Berta Solano Vila, Caridad Valero, Itziar Gastón, Jessica González Ardura, Carlos Ordás, Ioana Croitoru, Noemí Bernardo, Víctor Nogueira, Jon Infante, Manuel Seijo, Javier Miranda, Jaime Kulisevsky, Manuel Menéndez González, Silvia Jesús, Cristina Prieto, María Álvarez Sauco, Carlos Cores, Javier Rúiz Martínez, Luis Manuel López Díaz, Jorge Hernández Vara, Maria A. Ávila Rivera, Pablo Martinez-Martin, María José Martí, Monica M. Kurtis, Víctor Gómez Mayordomo, Sonia Escalante, Oriol de Fábregues, Pilar Sánchez Alonso, Víctor Puente, Lydia López Manzanares, Jose Manuel García Moreno, Francisco Carrillo Padilla, Mabel Morales-Casado
Publikováno v:
JOURNAL OF PARKINSONS DISEASE
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Journal of Parkinsons Disease
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Scientia
Journal of Parkinson's disease, 2023, 13(1), 105-124
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Journal of Parkinsons Disease
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Scientia
Journal of Parkinson's disease, 2023, 13(1), 105-124
Malaltia de Parkinson; Levodopa; Factors de risc Enfermedad de Parkinson; Levodopa; Factores de riesgo Parkinson Disease; Levodopa; Risk Factors Background:There is a need for identifying risk factors for hospitalization in Parkinson’s disease (PD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36cc1279e9aae5d881da00d8c9043924
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11833
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11833
Autor:
Sara Gomes, Alicia Garrido, Francesca Tonelli, Donina Obiang, Eduardo Tolosa, Maria José Martí, Javier Ruiz-Martínez, Ana Vinagre-Aragón, Haizea Hernandez-Eguiazu, Ioana Croitoru, Vicky L. Marshall, Theresa Koenig, Christoph Hotzy, Frank Hsieh, Marianna Sakalosh, Elizabeth Tengstrand, Shalini Padmanabhan, Kalpana Merchant, Christof Bruecke, Walter Pirker, Alexander Zimprich, Esther Sammler
Publikováno v:
npj Parkinson's Disease, Vol 9, Iss 1, Pp 1-4 (2023)
Abstract Elevated urine bis(monoacylglycerol)phosphate (BMP) levels have been found in gain-of-kinase function LRRK2 G2019S mutation carriers. Here, we have expanded urine BMP analysis to other Parkinson’s disease (PD) associated mutations and foun
Externí odkaz:
https://doaj.org/article/48b4e1d519164c9ca1e0284e3c294d10
Autor:
Gabriel Torrealba-Acosta, Eric Yu, Tanya Lobo-Prada, Javier Ruíz-Martínez, Ana Gorostidi-Pagola, Ziv Gan-Or, Kenneth Carazo-Céspedes, Jean-François Trempe, Ignacio F. Mata, Jaime Fornaguera-Trías
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/ec97e38b4e224e7c8da58d8fff9fcb50
Autor:
Lieven E. Gevers, Linga R. Enakonda, Ameen Shahid, Samy Ould-Chikh, Cristina I. Q. Silva, Pasi P. Paalanen, Antonio Aguilar-Tapia, Jean-Louis Hazemann, Mohamed Nejib Hedhili, Fei Wen, Javier Ruiz-Martínez
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-10 (2022)
The role of Ce one Mn-based catalysts for the selective catalytic reduction of NOx at low temperature is an ongoing debate. Here the authors demonstrate that Ce has a structural promoting effect but impacts negatively on the intrinsic catalytic activ
Externí odkaz:
https://doaj.org/article/c2af48e97c0a44baab17dfd660a6ceae